Ligand Pharmaceuticals Inc

LGND

As of the close on Sep 25, 2026

Price

$301.52

Market cap

$6.01B

P/E (diluted TTM)

—

The fourth quarter's per-share figure could not be confirmed from the annual report

EPS (TTM)

—

The fourth quarter's per-share figure could not be confirmed from the annual report

Dividend yield

—

Dividend records do not yet cover the latest payments

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How Ligand Pharmaceuticals Inc Makes Money

Follow each dollar of revenue through to what shareholders keep.

From revenue to net income

Pick a year or quarter. Each band's width is its dollar amount.

Source: Ligand Pharmaceuticals Inc — 10-Q filed Aug 7, 2026

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 18, 2026.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Unusually large insider trades

Each trade is compared with the other insider trades of the same kind in the same security among Ligand Pharmaceuticals Inc's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.

2026-06-12 · Haas Jason: Larger than 109 of the 114 other insider sales of Common Stock on file. SEC filing
2026-06-12 · Haas Jason: Larger than 104 of the 114 other insider sales of Common Stock on file. SEC filing
2026-06-11 · Aryeh Jason: Larger than 112 of the 114 other insider sales of Common Stock on file. SEC filing
2026-06-10 · LAMATTINA JOHN L: Larger than 107 of the 114 other insider sales of Common Stock on file. SEC filing
2026-03-11 · Espinoza Octavio: Larger than 106 of the 114 other insider sales of Common Stock on file. SEC filing
2026-03-04 · Espinoza Octavio: Larger than 108 of the 114 other insider sales of Common Stock on file. SEC filing
2026-03-04 · Espinoza Octavio: Larger than 103 of the 114 other insider sales of Common Stock on file. SEC filing
2025-11-07 · Gray Nancy Ryan: Larger than 110 of the 114 other insider sales of Common Stock on file. SEC filing
2025-11-07 · Gray Nancy Ryan: Larger than 105 of the 114 other insider sales of Common Stock on file. SEC filing
2025-09-23 · Aryeh Jason: Larger than 113 of the 114 other insider sales of Common Stock on file. SEC filing
2025-09-23 · Aryeh Jason: Larger than 111 of the 114 other insider sales of Common Stock on file. SEC filing
2025-03-04 · Espinoza Octavio: Larger than all 114 other insider sales of Common Stock on file. SEC filing

Independent insiders buying near the same time

2025-05-09–2025-05-09: 5 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing )

Purchases & sales (open market or private)

		Security	Code		Price	Filing
2026-06-16	Sabba Stephen L · Director	Common Stock	S — Open market or private sale	−2,145	254.00	SEC filing
2026-06-12	Haas Jason · Director	Common Stock	S — Open market or private sale	−3,000	255.01	SEC filing
2026-06-12	Haas Jason · Director	Common Stock	S — Open market or private sale	−3,461	256.08	SEC filing
2026-06-11	Aryeh Jason · Director	Common Stock	S — Open market or private sale	−4,500	250.00	SEC filing
2026-06-10	LAMATTINA JOHN L · Director	Common Stock	S — Open market or private sale	−257	247.22	SEC filing
2026-06-10	LAMATTINA JOHN L · Director	Common Stock	S — Open market or private sale	−232	248.11	SEC filing
2026-06-10	LAMATTINA JOHN L · Director	Common Stock	S — Open market or private sale	−3,405	251.62	SEC filing
2026-06-10	LAMATTINA JOHN L · Director	Common Stock	S — Open market or private sale	−697	249.53	SEC filing

Showing 8 of 15 rows

Grants, exercises, tax & gifts

		Security	Code		Filing
2026-06-16	Sabba Stephen L · Director	Common Stock	M — Exercise or conversion of derivative security	+2,145	SEC filing
2026-06-16	Sabba Stephen L · Director	Non-Qualified Stock Option (right to buy)	M — Exercise or conversion of derivative security	−2,145	SEC filing
2026-06-12	Haas Jason · Director	Common Stock	M — Exercise or conversion of derivative security	+3,000	SEC filing
2026-06-12	Haas Jason · Director	Non-Qualified Stock Option (right to buy)	M — Exercise or conversion of derivative security	−3,000	SEC filing
2026-06-12	Haas Jason · Director	Non-Qualified Stock Option (right to buy)	M — Exercise or conversion of derivative security	−1,000	SEC filing
2026-06-12	Haas Jason · Director	Common Stock	M — Exercise or conversion of derivative security	+1,000	SEC filing
2026-06-05	Sabba Stephen L · Director	Common Stock	A — Grant, award, or other acquisition	+836	SEC filing
2026-06-05	Gray Nancy Ryan · Director	Non-Qualified Stock Option (right to buy)	A — Grant, award, or other acquisition	+2,938	SEC filing

Showing 8 of 31 rows

Other activity

		Security	Code		Filing
2025-12-31	Espinoza Octavio · Chief Financial Officer	Common Stock	J — Other acquisition or disposition	+8	SEC filing
2025-06-30	Reardon Andrew · CLO & Secretary	Common Stock	J — Other acquisition or disposition	+233	SEC filing
2025-06-30	Espinoza Octavio · Chief Financial Officer	Common Stock	J — Other acquisition or disposition	+224	SEC filing
2025-06-30	Davis Todd C · Chief Executive Officer	Common Stock	J — Other acquisition or disposition	+233	SEC filing

Showing 4 of 4 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.